CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Phase III study of Ribociclib (LEE011) in combination with Fulvestrant for the treatment of postmenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) who have received no or only one line of prior endocrine treatment : MONALEESA-3
Author
Blackwell K.
De Laurentiis M.
+9Â more
Esteva F.J.
Fasching P.A.
JERUSALEM Guy
Lorenc K.R.
Martin M.
Paquet-Luzy T.
Pivot X.
Slamon D.J.
Tang Z.
Publication venue
'American Association for Cancer Research (AACR)'
Publication date
01/01/2016
Field of study
Full text link
peer reviewe
Open Repository and Bibliography - Liège